These findings support an important role for increased circulating endothelin-1 in the development of experimental hepatopulmonary syndrome and suggest that endothelin-1 and TNF-α have synergistic effects on the pulmonary microvasculature in portal hypertension [143]. The gene discussed is EDN1; the disease is hepatopulmonary syndrome.